Furthermore, elevated IFN-γ levels in week 16 in both the RO and ARO groups reinforce RO’s immunomodulatory role, given IFN-γ’s central function in activating CD8+ T-cell cytotoxicity and curbing tumor progression. This evidence concerns the gene IFNG and neoplasm.